Skip to main content

Table 2 Cycle number and reaction rate

From: Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysis

RTXa

7 (25%)

RTXb

19 (67.9%)

RTXc

1 (3.6%)

RTXd

1 (3.6%)

  1. NB. 22 patients had 28 reactions
  2. RTXa first infusion of the cycle, RTXb second, RTXc third and RTXd fourth
Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us